These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9794434)

  • 1. Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions.
    Ehlert JE; Gerdes J; Flad HD; Brandt E
    J Immunol; 1998 Nov; 161(9):4975-82. PubMed ID: 9794434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
    Malkowski MG; Lazar JB; Johnson PH; Edwards BF
    J Mol Biol; 1997 Feb; 266(2):367-80. PubMed ID: 9047370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
    Härter L; Petersen F; Flad HD; Brandt E
    J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
    Ehlert JE; Ludwig A; Grimm TA; Lindner B; Flad HD; Brandt E
    Blood; 2000 Nov; 96(9):2965-72. PubMed ID: 11049972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
    Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms.
    Rennen HJ; Frielink C; Brandt E; Zaat SA; Boerman OC; Oyen WJ; Corstens FH
    J Nucl Med; 2004 Jul; 45(7):1217-23. PubMed ID: 15235069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
    Car BD; Baggiolini M; Walz A
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.
    Wuyts A; D'Haese A; Cremers V; Menten P; Lenaerts JP; De Loof A; Heremans H; Proost P; Van Damme J
    J Immunol; 1999 Dec; 163(11):6155-63. PubMed ID: 10570306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration.
    Schenk BI; Petersen F; Flad HD; Brandt E
    J Immunol; 2002 Sep; 169(5):2602-10. PubMed ID: 12193731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). Comparison of native and recombinant NAP-2 variants.
    Ehlert JE; Petersen F; Kubbutat MH; Gerdes J; Flad HD; Brandt E
    J Biol Chem; 1995 Mar; 270(11):6338-44. PubMed ID: 7890771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms.
    Van Damme J; Rampart M; Conings R; Decock B; Van Osselaer N; Willems J; Billiau A
    Eur J Immunol; 1990 Sep; 20(9):2113-8. PubMed ID: 2145175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways. Discrepancies in binding affinities, receptor densities, and biologic effects.
    Petersen F; Flad HD; Brandt E
    J Immunol; 1994 Mar; 152(5):2467-78. PubMed ID: 8133058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased microvascular permeability in vivo in response to intradermal injection of neutrophil-activating protein (NAP-2) in rabbit skin.
    Van Osselaer N; Van Damme J; Rampart M; Herman AG
    Am J Pathol; 1991 Jan; 138(1):23-7. PubMed ID: 1824807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel molecular variant of the neutrophil-activating peptide NAP-2 with enhanced biological activity is truncated at the C-terminus: identification by antibodies with defined epitope specificity.
    Brandt E; Petersen F; Flad HD
    Mol Immunol; 1993 Aug; 30(11):979-91. PubMed ID: 7688853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
    Katancik JA; Sharma A; de Nardin E
    Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8.
    Qian YQ; Johanson KO; McDevitt P
    J Mol Biol; 1999 Dec; 294(5):1065-72. PubMed ID: 10600366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease.
    Mildner AM; Paddock DJ; LeCureux LW; Leone JW; Anderson DC; Tomasselli AG; Heinrikson RL
    Protein Expr Purif; 1999 Jul; 16(2):347-54. PubMed ID: 10419831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor.
    Schwartzkopff F; Brandt E; Petersen F; Flad HD; Bock L; Ludwig A
    J Interferon Cytokine Res; 2002 Feb; 22(2):257-67. PubMed ID: 11911809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.
    Brandt E; Petersen F; Ludwig A; Ehlert JE; Bock L; Flad HD
    J Leukoc Biol; 2000 Apr; 67(4):471-8. PubMed ID: 10770278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
    Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
    J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.